Regal Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
3,710
+324
+10% +$328K 0.2% 134
2025
Q4
$3.64M Buy
3,386
+636
+23% +$608K 0.22% 120
2025
Q3
$2.1M Buy
2,750
+249
+10% +$185K 0.14% 172
2025
Q2
$1.95M Buy
2,501
+115
+5% +$89.4K 0.15% 155
2025
Q1
$1.97M Sell
2,386
-852
-26% -$709K 0.16% 150
2024
Q4
$2.5M Sell
3,238
-1,350
-29% -$1.12M 0.19% 130
2024
Q3
$4.06M Sell
4,588
-735
-14% -$661K 0.28% 107
2024
Q2
$4.82M Buy
5,323
+16
+0.3% +$12.8K 0.31% 90
2024
Q1
$4.13M Buy
5,307
+499
+10% +$355K 0.28% 103
2023
Q4
$2.8M Buy
4,808
+1,405
+41% +$820K 0.21% 128
2023
Q3
$1.83M Buy
3,403
+148
+5% +$76.3K 0.15% 156
2023
Q2
$1.53M Buy
3,255
+473
+17% +$198K 0.13% 165
2023
Q1
$956K Sell
2,782
-450
-14% -$152K 0.08% 201
2022
Q4
$1.18M Sell
3,232
-271
-8% -$96.1K 0.11% 171
2022
Q3
$1.13M Buy
3,503
+333
+11% +$106K 0.12% 166
2022
Q2
$1.03M Buy
3,170
+642
+25% +$193K 0.11% 176
2022
Q1
$723K Buy
2,528
+9
+0.4% +$2.32K 0.07% 257
2021
Q4
$696K Buy
2,519
+136
+6% +$34.5K 0.06% 290
2021
Q3
$551K Buy
2,383
+37
+2% +$9.13K 0.05% 319
2021
Q2
$538K Buy
+2,346
New +$471K 0.05% 319
2021
Q1
Sell
-1,975
Closed -$333K 254
2020
Q4
$333K Buy
+1,975
New +$295K 0.04% 341
2020
Q3
Sell
-4,129
Closed -$678K 149
2020
Q2
$678K Buy
+4,129
New +$634K 0.12% 155
2019
Q2
Sell
-1,580
Closed -$205K 347
2019
Q1
$205K Sell
1,580
-826
-34% -$100K 0.04% 290
2018
Q4
$278K Sell
2,406
-678
-22% -$75.7K 0.06% 261
2018
Q3
$331K Buy
+3,084
New +$308K 0.07% 229
2018
Q2
Sell
-3,062
Closed -$237K 288
2018
Q1
$237K Buy
3,062
+408
+15% +$32.8K 0.05% 258
2017
Q4
$224K Sell
2,654
-254
-9% -$21.6K 0.05% 258
2017
Q3
$249K Buy
2,908
+273
+10% +$22.4K 0.06% 235
2017
Q2
$217K Buy
+2,635
New +$215K 0.05% 242
2015
Q4
Sell
-369
Closed -$30K 615
2015
Q3
$30K Buy
369
+46
+14% +$3.88K 0.01% 493
2015
Q2
$26K Buy
323
+50
+18% +$3.81K 0.01% 520
2015
Q1
$20K Buy
273
+25
+10% +$1.78K ﹤0.01% 566
2014
Q4
$17K Hold
248
﹤0.01% 561
2014
Q3
$16K Sell
248
-204
-45% -$12.9K ﹤0.01% 599
2014
Q2
$28K Buy
452
+159
+54% +$9.49K 0.01% 487
2014
Q1
$17K Sell
293
-387
-57% -$21.6K 0.01% 547
2013
Q4
$35K Sell
680
-218
-24% -$10.9K 0.02% 347
2013
Q3
$45K Sell
898
-83
-8% -$4.34K 0.03% 315
2013
Q2
$48K Buy
+981
New +$53.4K 0.03% 296

Other funds holding LLY

Regal Investment Advisors's LLY Position: Q1 2026 in Review

Regal Investment Advisors increased its Eli Lilly (LLY) stake by 9.6% in Q1 2026, buying an estimated $328K and bringing the position to 3,710 shares worth $3.41M. The position accounts for 0.2% of the portfolio, ranked #134.

Regal Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 39 quarters since. The position peaked at $4.82M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Regal Investment Advisors held 3,710 shares of Eli Lilly worth $3.41M as of Q1 2026.
  • Regal Investment Advisors bought 324 Eli Lilly shares in Q1 2026, an estimated $328K.
  • Eli Lilly made up 0.2% of Regal Investment Advisors's portfolio in Q1 2026, its #134 holding.
  • Regal Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 39 quarters since.
  • Regal Investment Advisors's Eli Lilly position peaked at $4.82M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.